The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1571-1580

  Ling, Paul D ^a   Lednicky, John A ^a,e   Keitel, Wendy A ^a   Poston, David G ^a   White, Zoe S ^a   Peng, RongSheng ^a   Liu, Zhensheng ^a,b,f   Mehta, Satish K ^c   Pierson, Duane L ^d   Rooney, Cliona M ^a,b   Vilchez, Regis A ^a   Smith, E O'Brian ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c Enterprise Advisory Services Inc   (United States)

^d NASA JOHNSON SPACE CENTER   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DYNAMICS; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; IMMUNOCOMPETENCE; LONGITUDINAL STUDY; MONOCYTE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SEASONAL VARIATION; TIME SERIES ANALYSIS; VIRUS REACTIVATION; VIRUS SHEDDING;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

ADULT; AGE FACTORS; BASE SEQUENCE; BK VIRUS; CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; JC VIRUS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SALIVA; SEASONS; TIME FACTORS; URINE; VIRUS ACTIVATION; VIRUS SHEDDING;

EID: 0038244888     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374739     Document Type: Article

References (56)

1. Kusne S, Krystofiak S. Infection control issues after bone marrow and solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections. Philadelphia: Lippincott-Raven, 1998:21-36.
2. Kusne S, Shapiro R, Fung J. Prevention and treatment of cytomegalovirus infection in organ transplant recipients. Transpl Infect Dis 1999; 1:187-203.
3. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343:481-92.
4. Kwak EJ, Vilchez RA, Randhawa P, Shapiro R, Butel JS, Kusne S. The pathogenesis and management of polyomaviruses in transplant recipients. Clin Infect Dis 2002; 35:1081-7.
5. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howlev PM, Griffin DE, et al., eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:2575-627.
6. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001; 1:75-82.
7. Crawford DH. Biology, and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:595-604.
8. Bonneau RH, Kiecolt-Glaser JK, Glaser R. Stress-induced modulation of the immune response. Ann N Y Acad Sci 1990; 594:253-69.
9. Glaser R, Rabin B, Chesney M, Cohen S, Natelson B. Stress-induced immunomodulation: implications for infectious diseases? JAMA 1999; 281:2268-70.
10. Mehta SK, Stowe RP, Feiveson AH, Tyring SK, Pierson DL. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 2000; 182:1761-4.
11. Stowe RP, Pierson DL, Barrett AD. Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts. Psychosom Med 2001; 63:891-5.
12. Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol 1989; 36:42-61.
13. Bogdanovic G, Brytting M, Cinque P, et al. Nested PCR for detection of BK virus and JC virus DNA. Clin Diagn Virol 1994; 2:211-20.
14. Dorries K, Vogel E, Gunther S, Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994; 198:59-70.
15. Azzi A, De Santis R, Ciappi S, et al. Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals. J Neurovirol 1996; 2:411-6.
16. Chatterjee M, Weyandt TB, Frisque RJ. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J Med Virol 2000; 60:353-62.
17. Lednickv JA, Butel JS. Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front Biosci 1999; 4:153-64.
18. Imperiale MJ. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology 2000; 267:1-7.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
20. Savoldo B, Huls MH, Liu Z, et al. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 2002; 100:4059-66.
21. Markowitz RB, Eaton BA, Kubik MF, Latorra D, McGregor JA, Dvnan WS. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol 1991; 65:4515-9.
22. Jin L, Gibson PE, Booth JC, Clewley JP. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J Med Virol 1993; 41:11-7.
23. Agostini HT, Ryschkewitsch CF, Stoner GL. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 1996; 34:159-64.
24. Jobes DV, Chima SC, Ryschkewitsch CF, Stoner GL. Phylogenetic analysis of 22 complete genomes of the human polyomavirus JC virus. J Gen Virol 1998; 79:2491-8.
25. Lednicky JA, Butel JS. A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infectedcell lysates and clinical samples. J Virol Methods 1997; 64:1-9.
26. Hara K, Sugimoto C, Kitamura T, Aoki N, Taguchi F, Yogo Y. Archetype JC virus efficientlv replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen. J Virol 1998; 72:5335-42.
27. Henle W, Henle G. The immunological approach to study of possibly virus-induced human malignancies using the Epstein-Barr virus as example. Prog Exp Tumor Res 1978; 21:19-48.
28. Yogo Y, Sugimoto C. The archetype concept and regulatory region rearrangement. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:127-48.
29. Agostini HT, Jobes DV, Stoner GL. Molecular evolution and epidemiology of JC virus. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:491-526.
30. Agostini HT, Ryschkewitsch CF, Stoner GL. JC virus type 1 has multiple subtypes: three new complete genomes. J Gen Virol 1998; 79:801-5.
31. Ault GS, Stoner GL. Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 1993; 74:1499-507.
32. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000; 283:499-505.
33. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984; 310:1225-30.
34. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 1991; 72:1579-90.
35. Apolloni A, Sculler TB. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 1994; 202:978-81.
36. Haque T, Crawford DH. PCR amplification is more sensitive than tissue culture methods for Epstein-Barr virus detection in clinical material. J Gen Virol 1997; 78:3357-60.
37. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect 2000; 2:115-20.
38. Brengel-Pesce K, Morand P, Schmuck A, et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 2002; 66:360-9.
39. Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR by HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet 1990; 335:1598-9.
40. Martinez OM, Villanueva JC, Lawrence-Mivasaki L, Quinn MB, Cox K, Krams SM. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation 1995; 59:519-24.
41. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37:132-6.
42. Dehee A, Asselot C, Piolot T, et al. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol 2001; 65:543-52.
43. Kitamura T, Aso Y, Kunivoshi N, Hara K, Yogo Y. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990; 161:1128-33.
44. Markowitz RB, Dynan WS. Binding of cellular proteins to the regulatory region of BK virus DNA. J Virol 1988; 62:3388-98.
45. Newman JT, Frisque RJ. Identification of JC virus variants in multiple tissues of pediatric and adult PML patients. J Med Virol 1999; 58:79-86.
46. Dörries K. Latent and persistent polyomavirus infection. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wilev-Liss, 2001:197-235.
47. Sugimoto C, Kitamura T, Guo J, et al. Typing of urinary JC virus DNA offers a novel means of tracing migrations. Proc Natl Acad Sci USA 1997; 94:9191-6.
48. Guo J, Sugimoto C, Kitamura T, et al. Four geographically distinct genotypes of JC virus are prevalent in China and Mongolia: implications for the racial composition of modern China. J Gen Virol 1998; 79:2499-505.
49. Hogan TF, Padgett BL, Walker DL, Borden EC, McBain JA. Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy. J Clin Microbiol 1980; 11:178-83.
50. Sundsfjord A, Flaegstad T, Flo R, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169:485-90.
51. Tsai RT, Wang M, Ou WC, et al. Incidence of JC viruria is higher than that of BK viruria in Taiwan. J Med Virol 1997; 52:253-7.
52. Krajden M, Shankaran P, Bourke C, Lau W. Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology. J Clin Microbiol 1996; 34:29-33.
53. Henderson YC, Liu TJ, Clayman GL. A simple and sensitive method for detecting adenovirus in serum and urine. J Virol Methods 1998; 71:51-6.
54. Tornatore C, Berger JR, Houff SA, et al. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992; 31:454-62.
55. Koralnik IJ, Schmitz JE, Lifton MA, Forman MA, Letvin NL. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J Neurovirol 1999; 5:430-5.
56. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52:253-60.